26.84 Billion in 2028
Rising incidence of cardiovascular diseases and increasing geriatric population are significant factor driving global interventional cardiology devices market growth.
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring & Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel
Feasibility
Customer Identification Survey
Competitive Landscape /
M&A Feasibility
Power & Energy
Oil and Gas, Electricity, Energy
Storage, Environmental, Renewable Energy
Information and Tech
Data Security, Cloud
Computing, IoT and Digitalization, Robotics, Telecom and Networking, Software and Services, Analytics, Semiconductor, Internet and E-Commerce
Materials and Chemicals
Organic Chemicals, Disinfectants and Preservatives, Adhesives and Sealants, Polymers and Resins, Petrochemicals, Agrochemicals and Fertilizers, Paints and Coatings
Food & Beverages
Foods & Beverage, Food Ingredients, Food Processing and Equipment, Food Testing and Supply Chain, Health
Food and Sports Nutrition, Frozen and Processed Food, Household, Retail
Automotive Services
Electric and Hybrid Vehicles, Off Highway and On Highway
Vehicles, Aftermarket and Maintenance, Automotive Parts, Interior and Exterior
Materials, Automotive electronics and Systems
Pharma & Healthcare
Medical Devices, Therapeutics, Biotechnology, Medical Imaging, Healthcare IT, Hospital Management, Diagnostics, Laboratory Equipment, Pharmaceutical
The global interventional cardiology devices market size is expected to reach USD 26.84 Billion at a steady CAGR of 8.7% in 2028, according to latest analysis by Emergen Research. Steady growth of the interventional cardiology devices market can be attributed to rising incidence of cardiovascular diseases. Cardiovascular disease is the most common cause of death in the US, and is responsible for around 655,000 deaths every year. Additionally, rising incidence of cardiovascular diseases result in an increase in healthcare expenditure, which in turn, is driving revenue growth of the interventional cardiology devices market. According to the Centers for Disease Control and Prevention, heart attacks account for over USD 320.00 Billion in yearly healthcare expenditure and lost productivity, and this figure is expected to reach USD 818.00 Billion in 2030.
www.emergenresearch.com
• In June 2019, Terumo Corporation signed a partnership agreement with Orchestra BioMed, Inc. This partnership provides Terumo Corporation with exclusive rights for the development and marketing of Virtue Sirolimus-Eluting Balloon (SEB).
• Angioplasty stents find application to restore blood flow occurring due to blockage and to reduce heart attack risk. Stents are considered beneficial in reducing damage caused to heart muscles in the event of a heart attack. Also, stents may instantly relieve or reduce symptoms comprising chest pain, fatigue, and shortness of breath.
• Among the end-use segments, the hospitals segment accounted for largest revenue share in 2020, which can be attributed to robust presence of experienced healthcare professionals for installation of interventional cardiology devices and more advanced and developed healthcare infrastructure, along with high purchasing power for advanced and dedicated interventional cardiology devices in countries in the region. Additionally, hospitals account for adverse event minimization in patients during critical procedures, including stent installation and cardiac catheterization.
Emergen Research has segmented the global interventional cardiology devices market on the basis of product type, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
Angioplasty Stents
Angioplasty Balloons
Catheters
Structural Heart Devices
Plaque Modification Devices
Guidewires
Hemodynamic Flow Alteration Devices
Others End-Use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Ambulatory Surgical Centers
Others
Read More@ https://www.emergenresearch.com/industry-report/interventional-cardiology-devices-market
Parameter Details
Market Size Estimation Period
2020-2028
Base Year Considered 2020
Historical Data
Forecast Period
2017-2019
2021-2028
Quantitative Units Revenue in USD million & CAGR from 2021 to 2028
Segments Covered Types, Application, End-Users, Regions & more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization & expert consultation
Pricing and Purchase Options
Explore Different Purchase Options & Request for Discount to Avail New Year Discount
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Our expertise umbrellas the technological environment of all major industries, and our services help you map your actions to ensure optimal yield. Our analysts utilize their market proficiency to offer actionable insights that help our clients implement profitable strategies and optimize their return on investment. Our services are wide-ranging, right from technological environment analysis to technological profiling that highlights the existing opportunities in the market you can capitalize
your competitors
